PENG Block Versus Epidural Block for Postoperative Analgesia After Total Hip Arthroplasty
Evaluation of Pericapsular Nerve Group (PENG) Block and Epidural Block for Postoperative Analgesia Following Total Hip Arthroplasty: a Comparative Study
This study aims to compare the effectiveness of ultrasound-guided Pericapsular Nerve Group (PENG) block and epidural block for postoperative analgesia in patients undergoing elective unilateral total hip arthroplasty. A total of 62 eligible patients will be randomly allocated into two groups: Group A will receive epidural block, and Group B will receive PENG block. Postoperative pain scores, opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization will be assessed to compare the analgesic efficacy and recovery outcomes of the two techniques.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Postoperative pain management is an important component of recovery following total hip arthroplasty. Epidural analgesia is an established regional anesthesia technique, whereas ultrasound-guided Pericapsular Nerve Group (PENG) block is a newer technique intended to provide targeted analgesia to the hip joint.
This single-blind, randomized controlled trial will compare these two techniques in 62 patients undergoing elective unilateral total hip arthroplasty at Bangladesh Medical University, Dhaka, Bangladesh.
Participants will be randomly assigned in a 1:1 ratio to receive either an epidural block or a PENG block. Both groups will receive standardized postoperative multimodal analgesia. Pain intensity will be assessed using the Numeric Rating Scale (NRS) at 0, 2, 4, 6, 12 and 24 hours after surgery. Additional outcomes will include total opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization.
The findings will help compare the analgesic effectiveness and postoperative recovery associated with these two regional anesthesia techniques.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Kazi Mahzabin Arin, MD
- Phone Number: 01754057689
- Email: kazimahzabinarin@bmu.ac.bd
Study Locations
-
-
-
Dhaka, Bangladesh, 1000
- Bangladesh Medical University
-
Contact:
- Kazi Mahzabin Arin, MD
- Phone Number: 01754057689
- Email: kazimahzabinarin@bmu.ac.bd
-
Principal Investigator:
- Suma Rani Paul
-
Sub-Investigator:
- Saiful Mahmud Tusher, FCPS
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged 18- 64 years, either sex
- Gender: Male and Female
- ASA physical status: I, II, or III
- Patients undergoing elective unilateral total hip arthroplasty
- Written informed consent obtained
Exclusion Criteria:
- Patient refusal to participate
- Known allergy to local anesthetics
- Infection at block site
- Coagulopathy (INR >1.5, Platelet <100,000/mm³)
- Neurological deficits in operated limb
- Chronic opioid use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Group A
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose with 3 mL of 2% lidocaine with adrenaline and 15-20 mL of 0.25% bupivacaine. |
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose and 15-20 mL of 0.25% bupivacaine. |
|
Experimental: Group B
Participants will receive an ultrasound-guided PENG block in the supine position before spinal anaesthesia, using a 22-gauge needle and 20 mL of 0.25% bupivacaine. |
Participants will receive an ultrasound-guided Pericapsular Nerve Group Block (PENG) block before induction in the supine position, using a 22G needle and 20 mL of 0.25% bupivacaine. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain score at rest and on movement using the Numeric Rating Scale (NRS)
Time Frame: At the recovery room- 0, 2, 4, 6, 12 and 24 hours after surgery
|
Pain intensity will be assessed using a 10-cm Numeric Rating Scale (NRS). The scale ranges from 0 to 10 cm, where 0 cm indicates no pain and 10 cm indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
At the recovery room- 0, 2, 4, 6, 12 and 24 hours after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to First Rescue Analgesia
Time Frame: Within 24 hours after surgery
|
Time from completion of surgery to the first administration of rescue analgesia (intravenous morphine 0.05 mg/kg when the Numeric Rating Scale pain score is 4 or higher). The time will be recorded in minutes. |
Within 24 hours after surgery
|
|
Total Opioid Consumption
Time Frame: Time Frame: First 24 hours after surgery.
|
Total amount of intravenous morphine administered as rescue analgesia to each participant during the first 24 hours after surgery, measured in milligrams (mg).T |
Time Frame: First 24 hours after surgery.
|
|
Postoperative Motor Blockade
Time Frame: At the recovery room- 0, 2, 6 hours after surgery
|
Motor blockade will be assessed using the Modified Bromage Scale, ranging from 0 to 3. A score of 0 indicates no motor block, while a score of 3 indicates complete motor block with inability to move the hip, knee, and ankle. Higher scores indicate greater motor blockade. |
At the recovery room- 0, 2, 6 hours after surgery
|
|
Postoperative Adverse Effects
Time Frame: First 24 hours after surgery
|
Description: The occurrence of postoperative adverse effects, including hypotension, nausea, vomiting, and urinary retention, will be recorded for each participant. Each adverse effect will be documented as present or absent. |
First 24 hours after surgery
|
|
Time to First Mobilization
Time Frame: Within 24 hours after surgery
|
Time from surgery completion until the participant first stands or walks. The time will be recorded in minutes. |
Within 24 hours after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.
- Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.
- Sloan M, Premkumar A, Sheth NP. Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018 Sep 5;100(17):1455-1460. doi: 10.2106/JBJS.17.01617.
- Kehlet H. Fast-track hip and knee arthroplasty. Lancet. 2013 May 11;381(9878):1600-2. doi: 10.1016/S0140-6736(13)61003-X. No abstract available.
- Pascarella G, Costa F, Del Buono R, Pulitano R, Strumia A, Piliego C, De Quattro E, Cataldo R, Agro FE, Carassiti M; collaborators. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial. Anaesthesia. 2021 Nov;76(11):1492-1498. doi: 10.1111/anae.15536. Epub 2021 Jul 1.
- Pai P, Amor D, Lai YH, Echevarria GC. Use and Clinical Relevancy of Pericapsular Nerve Block (PENG) in Total Hip Arthroplasty: A Systematic Review and Meta-analysis. Clin J Pain. 2024 May 1;40(5):320-332. doi: 10.1097/AJP.0000000000001196.
- Staikou C, Rekatsina M, Leoni MLG, Chamos C, Kapsokalyvas I, Varrassi G, Karmaniolou I. Efficacy and Safety of Pericapsular Nerve Group Block (PENG) in Hip Surgery Under General Anaesthesia: A Systematic Literature Review and Meta-Analysis. J Clin Med. 2025 Jan 13;14(2):468. doi: 10.3390/jcm14020468.
- Reysner T, Kowalski G, Mularski A, Reysner M, Wieczorowska-Tobis K. From Pain Control to Early Mobility: The Evolution of Regional Anesthesia in Geriatric Total Hip Arthroplasty. Reports (MDPI). 2025 May 9;8(2):64. doi: 10.3390/reports8020064.
- Pires Sousa I, Leite da Silva Peixoto CI, Fernandes Coimbra LA, da Costa Rodrigues FM. Comparison of pericapsular nerve group (PENG) block and epidural analgesia following total hip arthroplasty: A retrospective analysis. Rev Esp Anestesiol Reanim (Engl Ed). 2022 Dec;69(10):632-639. doi: 10.1016/j.redare.2022.10.002. Epub 2022 Nov 12.
- Lee KH, Wang JC, Chang CY, Teng WN, Wang HY, Lee CC, Tsai SW, Chen CF, Wu PK, Chen WM. Regional anaesthesia modalities for primary total hip arthroplasty: a systematic review and component network meta-analysis. Br J Anaesth. 2025 Aug;135(2):469-482. doi: 10.1016/j.bja.2025.04.019. Epub 2025 Jun 6.
- Evangelista T, Pugno C, Finazzi S, Colombi A, Bugada D. Regional anesthesia for hip surgery: A review of current approaches and their application to clinical practice. Saudi J Anaesth. 2025 Apr-Jun;19(2):164-173. doi: 10.4103/sja.sja_68_25. Epub 2025 Mar 25.
- de Souza DN, Lorentz NA, Charalambous L, Galetta M, Petrilli C, Rozell JC. Comprehensive Pain Management in Total Joint Arthroplasty: A Review of Contemporary Approaches. J Clin Med. 2024 Nov 13;13(22):6819. doi: 10.3390/jcm13226819.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BMU/2026/20/000013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.